NEW YORK (Reuters Health) – Pooled data suggest that cancer patients who are treated with sunitinib (Sutent; Pfizer) have about a 2-fold increased relative risk of developing high-grade…
NEW YORK (Reuters Health) – For women giving birth, a high-dose oxytocin regimen results in a shorter duration of labor without increasing the c-section rate or adversely affecting…
NEW YORK (Reuters Health) – Weight-based insulin doses up to 0.6 unit/kg are associated with a low risk of hypoglycemia, according to a report in the June 23rd…
NEW YORK (Reuters Health) – When used as adjuvant therapy in high-risk breast cancer or as primary treatment for metastatic breast cancer, high-dose chemotherapy (HDC) with autologous stem-cell…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation on amiodarone, the incidence of thyroid dysfunction is identical in those taking the brand-name formulation of the drug…
NEW YORK (Reuters Health) – Giving elderly patients with acute MI a clopidogrel loading dose of 300 mg or more rather than a lower conventional dose doesn’t increase…
NEW YORK (Reuters Health) – In patients with atrial fibrillation (AF), combination antithrombotic therapy with an anticoagulant and an antiplatelet increases the risk for clinically relevant bleeding with…
NEW YORK (Reuters Health) – Bronchodilation is well maintained in patients with chronic obstructive pulmonary disease (COPD) using the long-acting beta-2-agonist indacaterol during 1 year of treatment, investigators…
NEW YORK (Reuters Health) – An investigational drug AMR101 containing purified eicosapentaenoic acid and no docosahexaenoic acid reduces very high triglyceride levels by up to 45% compared to…
NEW YORK (Reuters Health) – While angiotensin receptor blockers (ARBs) as a class do not appear to be associated with an increased malignancy risk in patients with diabetes,…